Spots Global Cancer Trial Database for Patient Reported Outcomes/Metrics Program Trial

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Patient Reported Outcomes/Metrics Program Trial

Official Title: Patient Reported Outcomes/Metrics Program Trial - Palliative Radiation

Study ID: NCT04983199

Conditions

Metastatic Cancer

Palliative

Interventions

Hexoskin Medical System

Study Description

Brief Summary: This is an observational study to investigate if it is feasible to recruit 100 patients receiving radiotherapy (RT) to metastatic disease to wear Hexoskin and if Hexoskin will facilitate the monitoring, detection and early treatment of RT-related side effects.

Detailed Description: Radiotherapy is an important adjunct in the interdisciplinary care of the palliative patient population, providing the potential for improved quality of life and symptom control, often translating into improved well-being, function and mobility. Changes in pain and QOL are frequently measured subjectively using patient-reported questionnaires. Objective measures such as respiratory rate, pulse rate, activity level and sleep duration and quality, may complement the currently available tools. Such tools may lead to better evaluation of the effects of palliative RT with real-time detection of potential complications and toxicity and the acute need for analgesic adjustments that can result from successful palliative RT.